Febuxostat is a urate-lowering drug, indicated for the treatment of hyperuricemia and gout. During the process development of febuxostat, nine process related impurities were observed at a level of 0.1-0.15 area percent. Synthesis and characterization of these impurities and investigation of their formation is described.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 11575 citations as per Google Scholar report